Skip to main content

Introduction

  • Chapter
  • First Online:
  • 1990 Accesses

Abstract

Marfan syndrome is generally thought to be rare, but clinicians who have seen how the gene expression can shade into normality in affected members of a family, suspect that its overall frequency could be underestimated, as a recent collaborative publication states [1]. The fact that the syndrome presents in many different ways may also hinder its recognition. Marfan syndrome patients may first be referred to any one of a number of specialists. Each doctor is likely to be familiar with a particular aspect of the syndrome, but less familiar with its other features. The aim of this guide is to pool the knowledge available from different experienced specialists, and to make it available to the many clinicians likely to encounter a patient with this condition.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Arslan-Kirchner M, Arbustini E, Boileau C, et al. Clinical utility gene card for: marfan syndrome type 1 and related phenotypes [FBN1]. Eur J Hum Genet. 2010;18(9): doi: 10.1038/ejhg.2010.42.

    Google Scholar 

  2. Pyeritz RE. Marfan syndrome: 30 years of research equals 30 years of additional life expectancy. Heart. 2009;95(3):173–5.

    Article  PubMed  Google Scholar 

  3. Pitcher A, Emberson J, Lacro RV, et al. Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: a report from the Marfan Treatment Trialists’ Collaboration. Am Heart J. 2015;169(5):605–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Milewicz DM, Regalado E. Thoracic aortic aneurysms and aortic dissections. www.ncbi.nlm.nih.gov/books/NBK1120/.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anne H. Child MD, FRCP .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag London

About this chapter

Cite this chapter

Child, A.H. (2016). Introduction. In: Child, A. (eds) Diagnosis and Management of Marfan Syndrome. Springer, London. https://doi.org/10.1007/978-1-4471-5442-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-5442-6_1

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-5441-9

  • Online ISBN: 978-1-4471-5442-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics